Your browser doesn't support javascript.
loading
A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612.
Assouline, Sarit; Michaelis, Laura C; Othus, Megan; Hay, Annette E; Walter, Roland B; Jacoby, Meagan A; Schroeder, Mark A; Uy, Geoffrey L; Law, Lisa Y; Cheema, Faisal; Sweet, Kendra L; Asch, Adam S; Liu, Jijun Jane; Moseley, Anna B; Maher, Tracy; Kingsbury, Laura L; Fang, Min; Radich, Jerald; Little, Richard F; Erba, Harry P.
Afiliação
  • Assouline S; McGill University - Jewish General Hospital, Montreal, Canada.
  • Michaelis LC; Medical College of Wisconsin, Milwaukee, WI, USA.
  • Othus M; SWOG Statistics and Data Management Center, Seattle, WA, USA.
  • Hay AE; Queen's University, Kingston, Canada.
  • Walter RB; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Jacoby MA; Washington University School of Medicine, St. Louis, MO, USA.
  • Schroeder MA; Washington University School of Medicine, St. Louis, MO, USA.
  • Uy GL; Washington University School of Medicine, St. Louis, MO, USA.
  • Law LY; Kaiser Permanente NCAL, Roseville, CA, USA.
  • Cheema F; Kaiser Permanente, Santa Clara, CA, USA.
  • Sweet KL; Moffitt Cancer Center, Tampa, FL, USA.
  • Asch AS; University of Oklahoma HSC, Oklahoma City, OK, USA.
  • Liu JJ; Illinois CancerCare/Heartland NCORP, Peoria, IL, USA.
  • Moseley AB; Medical College of Wisconsin, Milwaukee, WI, USA.
  • Maher T; SWOG Data Operations Center/Cancer Research and Biostatistics, Seattle, WA, USA.
  • Kingsbury LL; SWOG Data Operations Center/Cancer Research and Biostatistics, Seattle, WA, USA.
  • Fang M; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Radich J; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Little RF; Cancer Therapy and Evaluation Program (CTEP), National Cancer Institute, Bethesda, MD, USA.
  • Erba HP; Duke University Medical Center, Duke Cancer Institute, Durham, NC, USA.
Leuk Lymphoma ; 64(2): 473-477, 2023 02.
Article em En | MEDLINE | ID: mdl-36517990
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mielomonocítica Crônica / Leucemia Mieloide Aguda Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Revista: Leuk Lymphoma Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mielomonocítica Crônica / Leucemia Mieloide Aguda Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Revista: Leuk Lymphoma Ano de publicação: 2023 Tipo de documento: Article